Treatment with RhoA siRNA resulted in increased levels of F-actin (Fig. 1h–j), suggesting a role for increased RhoA protein expression in the cell structural changes observed in ARPKD tissues. Here, RHOA is linked to autosomal recessive polycystic kidney disease.